Health Canada

Health Canada Grants Conditional Approval to Leqembi® (lecanemab) for Early Alzheimer’s Disease

Health Canada Grants Conditional Approval to Leqembi® (lecanemab) for Early Alzheimer’s Disease

28 Oct 2025

2 min read

Health Canada Approves Biocon Biologics’ Yesintek and Yesintek I.V., Biosimilars of Stelara, for Multiple Autoimmune Conditions

Health Canada Approves Biocon Biologics’ Yesintek and Yesintek I.V., Biosimilars of Stelara, for Multiple Autoimmune Conditions

24 Oct 2025

1 min read

Health Canada Approves OPDIVO + YERVOY as First-Line Treatment for Colorectal and Liver Cancers

Precision Medicine

Health Canada Approves OPDIVO + YERVOY as First-Line Treatment for Colorectal and Liver Cancers

20 Aug 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com